-
.
.
why novartis� landmark cancer drug approval is great news for bluebird
.
.
.�now we know the astonishing truth that some patients are waiting a year or more just to get treatment. it�s simply not good enough.�
http://lm360.us/Ringquist-mother-of-Soens-from-Warsaw?Kniffengr=173
�now we know the astonishing truth that some patients are waiting a year or more just to get treatment. it�s simply not good enough.� http://lm360.us/Ringquist-mother-of-Soens-from-Warsaw?Kniffengr=173